Moderna vaccine 96 percent effective in 12-17 year-olds, study shows

Moderna said Thursday its COVID-19 vaccine is 96 percent effective among youths aged 12 to 17, according to the results of its first clinical trials.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.